Along with the increase in the value of the pharmaceutical industry in Mexico, the number of establishments and jobs has increased steadily, its highest increase since 2013, the last year in which it has been registered, by the Manufacturing Industry.
Mexico is the second largest market in Latin America in the pharmaceutical industry, and is an important producer of high-tech medicines, including antibiotics, anti-inflammatories and cancer treatments, among others. Likewise, 14 of the 15 main international companies are located in the country, which is why Mexico has positioned itself as one of the main manufacturing centers worldwide.
According to data from the National Institute of Statistics and Geography (INEGI), the Pharmaceutical Industry showed a growth trend in the number of establishments dedicated to this activity, having a current record of 770 economic units.
The institute also recorded that, there are three states that stand out due to the concentration of 61.5% of the establishments dedicated to the sale of drugs. These federal entities are: Mexico City with 32% of the economic units; Jalisco, which concentrated 20%; and the state of Mexico, 9.5 percent.
Hand in hand with the increase of economic units in this sector, it is forecast that by 2020 the Mexican consumption of the pharmaceutical industry will be around 26.2Billion dollars, which represents an increase of 100% compared to 2011.
Currently, the pharmaceutical sector generates approximately 65,204 jobs. Some of the main transnational companies in the industry are: Merck, Boehringer Ingelheim, Schering Plow and Byer, among others. And national like: Liomont, Sanfer, Armstrong Laboratories and Hormone Laboratories.
Mexico is one of the most attractive markets to invest in the pharmaceutical industry due to the improvement of the regulatory framework and increase in quality certifications. According to Business Monitor, the presence of the FDA in Mexico has served to increase transparency and increase the standards of medicines in the country.